TP53 and neoplasm: Under the condition of radiotherapy, DNA damage and miR-125a-5p can induce DSBs and rH2AX phosphorylation in tumors, as well as activate p53 through the DDR pathway, thereby inhibiting tumor cell repair and enhancing the radiotherapy effect of tumor cells.